Biocon Biologics' new mAbs facility receives EU GMP Certification for bBevacizumab
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
The company has received the Certificate of GMP Compliance from the representative European inspection authority, Health Products Regulatory Authority (HPRA), Ireland.
This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.
The EU certification will support supplies of drug products registered in Europe, from this manufacturing site
The facility will manufacture its Herceptin biosimilar, Tuznue
Subscribe To Our Newsletter & Stay Updated